首页 | 本学科首页   官方微博 | 高级检索  
     


Membranous Lupus Nephritis in a Renal Allograft: Response to Mycophenolate Mofetil Therapy
Authors:Mark D. Denton   Eleonora G. Galvanek  Ajay Singh   Mohamed H. Sayegh
Affiliation:Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. dentonmd@gis.net
Abstract:
Membranous lupus nephritis in a renal allograft is considered rare. A 43-year-old man with quiescent systemic lupus erythematosus (SLE) received a HLA identical transplant from his sister and 4 years later developed persistent nephrotic range proteinuria and morphological features most compatible with membranous lupus nephritis on biopsy. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists, although successful in reducing proteinuria, were associated on three occasions with acute allograft dysfunction. Sustained reduction of proteinuria and stable graft function were achieved using mycophenolate mofetil (MMF). MMF is emerging as a new therapy for primary renal disease in SLE. This is the first report of successful treatment of membranous lupus nephritis in an allograft using MMF. We review all cases of transplant-associated membranous lupus nephritis in the English literature.
Keywords:Mycophenolate mofetil    nephrotic syndrome    systemic lupus nephritis    transplantation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号